Epigenetics of Estrogen Receptor Signaling in Hormonal Cancer
Author Information
Author(s): Mann Monica, Cortez Valerie, Vadlamudi Ratna K.
Primary Institution: Department of Cellular and Structural Biology, UTHSCSA
Hypothesis
Estrogen receptor (ERα) signaling contributes to epigenetic changes that affect hormonal cancer progression and therapy.
Conclusion
The study highlights the role of ERα-mediated histone modifications in cancer progression and suggests targeting these pathways for therapeutic opportunities.
Supporting Evidence
- ERα is a key transcriptional regulator in breast cancer biology.
- Estrogen stimulation induces several histone modifications at ERα target gene promoters.
- Deregulation of enzymes involved in the ERα-mediated epigenetic pathway could play a vital role in ERα driven neoplastic processes.
- Epigenetic changes are reversible, offering novel therapeutic opportunities.
Takeaway
This study explains how estrogen affects cancer by changing the way genes are turned on and off, which could help us find new treatments.
Methodology
The review summarizes current knowledge on mechanisms by which ERα signaling potentiates epigenetic changes in cancer cells via histone modifications.
Limitations
The review does not provide original experimental data and relies on existing literature.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website